» Articles » PMID: 21098022

Amino Acid Residues Constituting the Agonist Binding Site of the Human P2X3 Receptor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Nov 25
PMID 21098022
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Homomeric P2X3 receptors are present in sensory ganglia and participate in pain perception. Amino acid (AA) residues were replaced in the four supposed nucleotide binding segments (NBSs) of the human (h) P2X3 receptor by alanine, and these mutants were expressed in HEK293 cells and Xenopus laevis oocytes. Patch clamp and two-electrode voltage clamp measurements as well as the Ca(2+) imaging technique were used to compare the concentration-response curves of the selective P2X1,3 agonist α,β-methylene ATP obtained at the wild-type P2X3 receptor and its NBS mutants. Within these NBSs, certain Gly (Gly-66), Lys (Lys-63, Lys-176, Lys-284, Lys-299), Asn (Asn-177, Asn-279), Arg (Arg-281, Arg-295), and Thr (Thr-172) residues were of great importance for a full agonist response. However, the replacement of further AAs in the NBSs by Ala also appeared to modify the amplitude of the current and/or [Ca(2+)](i) responses, although sometimes to a minor degree. The agonist potency decrease was additive after the simultaneous replacement of two adjacent AAs by Ala (K65A/G66A, F171A/T172A, N279A/F280A, F280A/R281A) but was not altered after Ala substitution of two non-adjacent AAs within the same NBS (F171A/N177A). SDS-PAGE in the Cy5 cell surface-labeled form demonstrated that the mutants appeared at the cell surface in oocytes. Thus, groups of AAs organized in NBSs rather than individual amino acids appear to be responsible for agonist binding at the hP2X3 receptor. These NBSs are located at the interface of the three subunits forming a functional receptor.

Citing Articles

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists.

Sheng D, Yue C, Jin F, Wang Y, Ichikawa M, Yu Y Elife. 2024; 12.

PMID: 38578670 PMC: 10997329. DOI: 10.7554/eLife.92829.


P2X2 receptor subunit interfaces are missense variant hotspots, where mutations tend to increase apparent ATP affinity.

Gasparri F, Sarkar D, Bielickaite S, Poulsen M, Hauser A, Pless S Br J Pharmacol. 2022; 179(14):3859-3874.

PMID: 35285517 PMC: 9314836. DOI: 10.1111/bph.15830.


The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel.

Stephan G, Huang L, Tang Y, Vilotti S, Fabbretti E, Yu Y Nat Commun. 2018; 9(1):1354.

PMID: 29636447 PMC: 5893604. DOI: 10.1038/s41467-018-03728-5.


Inter-subunit disulfide locking of the human P2X3 receptor elucidates ectodomain movements associated with channel gating.

Stephan G, Kowalski-Jahn M, Zens C, Schmalzing G, Illes P, Hausmann R Purinergic Signal. 2016; 12(2):221-33.

PMID: 26825305 PMC: 4854835. DOI: 10.1007/s11302-016-9496-5.


Key sites for P2X receptor function and multimerization: overview of mutagenesis studies on a structural basis.

Hausmann R, Kless A, Schmalzing G Curr Med Chem. 2014; 22(7):799-818.

PMID: 25439586 PMC: 4460280. DOI: 10.2174/0929867322666141128163215.


References
1.
Ennion S, Hagan S, Evans R . The role of positively charged amino acids in ATP recognition by human P2X(1) receptors. J Biol Chem. 2000; 275(38):29361-7. DOI: 10.1074/jbc.M003637200. View

2.
Ding S, Sachs F . Single channel properties of P2X2 purinoceptors. J Gen Physiol. 1999; 113(5):695-720. PMC: 2222910. DOI: 10.1085/jgp.113.5.695. View

3.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

4.
Koshimizu T, Koshimizu M, Stojilkovic S . Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem. 1999; 274(53):37651-7. DOI: 10.1074/jbc.274.53.37651. View

5.
Freist W, Verhey J, Stuhmer W, Gauss D . ATP binding site of P2X channel proteins: structural similarities with class II aminoacyl-tRNA synthetases. FEBS Lett. 1998; 434(1-2):61-5. DOI: 10.1016/s0014-5793(98)00958-2. View